Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Endari for the Treatment of Sickle Cell Disease

Drug (Brand / Generic)

Endari™ (L-glutamine oral powder)

Developer

Emmaus Life Sciences

Current Indication

Sickle cell anaemia and sickle ߺ thalassemia

Market Sector

Genetics

Development Status

Approved in the US
Expand

Go Top